Gene: myosin binding protein C, cardiac; MYBPC3


Gene Symbol: MYBPC3
OMIM: 600958
Chromosome location: 11p11.2

Related informations:  NCBI Gene  Genome Browser  Ensembl  UniProt  GeneCards  Kyoto Encyclopedia  BioGPS  HGNC  HPRD  

Cardiomyopathy, familial hypertrophic, 1 || c.1928-2A>G

Phenotype:    Cardiomyopathy, familial hypertrophic, 1
Dna Change:    c.1928-2A>G
Protein Change:   
Mutation Type:    Substitution
Mutation Effect:    Splice site
Location:    intron 20
Transcript:    NM_000256.3

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
FranceNANA34 patients/9 unrelated familiesNATeirlinck CH et al., 2012Teirlinck CH, Senni F, Malti RE, Majoor-Krakauer D, Fellmann F, Millat G, André-Fouët X, Pernot F, Stumpf M, Boutarin J, Bouvagnet P, . A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death.. BMC Med. Genet.. 2012; 13(0):105

Cardiomyopathy, familial hypertrophic, 4 || c.772G>A

Phenotype:    Cardiomyopathy, familial hypertrophic, 4
Dna Change:    c.772G>A
Protein Change:    p.Glu258Lys
Mutation Type:    Substitution
Mutation Effect:    Missense
Location:    exon 6
Transcript:    NM_000256.3

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
ItalyNANA14%NAGirolami F et al., 2006Girolami F, Olivotto I, Passerini I, Zachara E, Nistri S, Re F, Fantini S, Baldini K, Torricelli F, Cecchi F, . A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.. J Cardiovasc Med (Hagerstown). 2006; 7(8):601-7

Cardiomyopathy, familial hypertrophic, 4 || c.913_914delTT

Phenotype:    Cardiomyopathy, familial hypertrophic, 4
Dna Change:    c.913_914delTT
Protein Change:    p.Phe305Profs*27
Mutation Type:    Deletion
Mutation Effect:    Frameshift
Location:    exon 11
Transcript:    NM_000256.3

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
ItalyNANA19.5% (19 patients/97 patients)NACalore C et al., 2015Calore C, De Bortoli M, Romualdi C, Lorenzon A, Angelini A, Basso C, Thiene G, Iliceto S, Rampazzo A, Melacini P, . A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.. J. Med. Genet.. 2015; 0(0):

References

Calore C, De Bortoli M, Romualdi C, Lorenzon A, Angelini A, Basso C, Thiene G, Iliceto S, Rampazzo A, Melacini P, A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.J. Med. Genet.. 2015; 0(0):

Girolami F, Olivotto I, Passerini I, Zachara E, Nistri S, Re F, Fantini S, Baldini K, Torricelli F, Cecchi F, A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.J Cardiovasc Med (Hagerstown). 2006; 7(8):601-7

Teirlinck CH, Senni F, Malti RE, Majoor-Krakauer D, Fellmann F, Millat G, André-Fouët X, Pernot F, Stumpf M, Boutarin J, Bouvagnet P, A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death.BMC Med. Genet.. 2012; 13(0):105